LITS
Lite Strategy, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.14
+9.62%Next report
Analyst consensus
- Next report date
- Sep 28, 2026
- EPS estimate
- -$3.12
- Revenue estimate
- $5.4M
Latest reported
- Last report date
- May 13, 2026
- EPS actual
- -$0.66
- EPS estimate
- -$3.12
- Revenue actual
- —
- Revenue estimate
- $5.4M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +43.1%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Sep 28, 2026